December 11, 2013

A subsidiary of Actavis has reached a settlement with a generic drug maker that will allow the launch of a generic version of a treatment for ulcerative colitis in 2015.

December 10, 2013

CVS Caremark and Cardinal Health announced on Tuesday the signing of an agreement to form the largest generic sourcing entity in the United States.

December 9, 2013

Covidien will acquire a company that markets a swallowed capsule used in medical imaging for $860 million, the hospital equipment manufacturer said Sunday.

December 4, 2013

Cardinal Health Foundation recently awarded more than $350,000 in grant funding to 29 nonprofit organizations that are dedicated to the fight against prescription drug abuse, the organization announced Wednesday.

December 3, 2013

Cardinal Health recently enhanced its Reimbursement Consulting Services offering, which helps retail pharmacies ensure the accuracy of third-party reimbursement by identifying reimbursement errors and recommending strategies for correcting them.

November 26, 2013

Cardinal Health on Tuesday announced that it has renewed a three-year agreement with Prime Therapeutics to continue serving as the primary pharmaceutical supplier for Prime's pharmacy home-delivery service, PrimeMail, and for Prime Therapeutics Specialty Pharmacy.

November 22, 2013

The shareholders of Elan Corp. approved the acquisition of the company by Perrigo Co. at two special meetings.

November 21, 2013

Actavis will lay off more than 30% of the sales staff from its branded-drugs division as part of its acquisition of Warner Chilcott, the drug maker said.

November 18, 2013

Drug maker Actavis hopes to become the first to market with a generic version of a topical testosterone replacement drug marketed by Eli Lilly, Actavis said.

November 11, 2013

Shire will pay $4.2 billion to buy a drug maker specializing in treatments for rare diseases.

October 31, 2013

Actavis is seeking Food and Drug Administration approval for a generic drug used to treat acne, triggering a lawsuit in a federal court from the maker of the branded version, the company said Thursday.

October 31, 2013

Cardinal Health had sales of $24.5 billion and profits of $339 million in first quarter 2014, the company said.

October 30, 2013

Tria Beauty, a maker of light-based skin care, has received FDA clearance for the company's Age-Defying Laser, the company has announced.

October 29, 2013

Actavis had sales of $2.01 billion in third quarter 2013, a 57% increase over the same period last year, the drug maker said Tuesday.

October 29, 2013

Actavis hopes to become the first company to market a generic version of a drug used to treat acne in adolescents and adults, the company said.

October 15, 2013

Actavis is hoping to become the first to market a generic version of a drug used to treat patients who have become dependent on opioid drugs, triggering a lawsuit from the branded drug's manufacturer.

October 2, 2013

Actavis has appointed the board of directors for the division it recently created as part of its acquisition of Ireland-based Warner Chilcott, the drug maker said.

October 1, 2013

Ireland's High Court has approved Actavis' acquisition of Warner Chilcott, the drug makers said.

September 5, 2013

Japanese drug maker Otsuka Pharmaceutical Co. is buying U.S.-based Astex Pharmaceuticals for $886 million, Otsuka said Thursday.

September 4, 2013

Cardinal Health announced that its board of directors has elected Patricia Hemingway Hall, president and CEO of Health Care Service Corp., as an independent director, effective Sept. 12.

September 3, 2013

With the window for Medicare enrollment opening on Oct. 15 and running through Dec. 7, Cardinal Health on Tuesday launched a customizable Medicare Enrollment Toolkit to help its retail pharmacy customers educate the rapidly growing Medicare-eligible population about coverage options.

August 29, 2013

Cardinal Health on Tuesday announced that Tony Caprio, EVP in the Office of Customer Experience and general manager for the Healthcare IQ business partnership, will retire from the company after nearly 40 years of service to the healthcare community.

August 1, 2013

Cardinal Health is significantly bullish heading into fiscal 2014. And for good reason. Not only does the graying of the baby boomers continue to represent a strong tailwind, but there are five other factors that will help fill those sails as well, George Barrett, Cardinal chairman and CEO, told investors Thursday morning.

July 10, 2013

Tria Beauty, a maker of laser and light-based skin care products, has announced the closing of $45.5 million in new equity financing and a new structured debt facility.